Scientific evidence of anti -COVID 19 mRNA and vectorial  vaccines genotoxicity inducing tumors and psycho-neuro-behavioral disorders

  • November 2021


. Micro-RNAs (miR) are non-coding RNA filaments that control mRNA transcription. Micro-RNAs have been studied in cancer pathogenesis, metastasization, cancer therapy, the structuring of the central nervous system, diabetes, and heart disease.   Mir-134-138 regulate the development of dendritic spines needed for synapses. Their silencing can lead to autistic spectrum disorders and mental retardation and damage to brains in evolution such as childhood and adolescence, producing learning problems and mood problems, and in adults for alterations of receptors for neurotransmission.  It has been shown that N1-methyl pseudouridine binds to miR and induces silencing processes, increasing cell methylome at the origin of cancer. The production of mRNA vaccines replaces Uridine with N1-methyl-pseudouridine to escape innate immunity and implement rapid translation. N1-methyl-pseudouridine  binding with mi-RNA alters the epigenetic transcription of oncosuppressor that, with the increase in cell methylation, could result in the induction of tumors and relapses, natural immunity inhibition, and neuro-behavioral disorders transmissible to progeny. Vectorial vaccines hybridize the host DNA with adenoviruses and induce tumors at the experimental level. Clinical reports and long-term epidemiological investigations are necessary to verify the impact of mRNA vaccines on health.

Full text






Inaugural Conference of  the 2020-2021  academic activities of Ambrosiana University



The Person-Centered Prevention Program  for pandemic prevention



Person-Centred Medicine (PCM) is the current paradigm of medical science and Medicine, and this involves the orientation of public health with a new organization of primary care and the training of doctors and students in Medicine through teachers prepared for PCM teaching. Its application, through trained doctors, allows enormous savings in suffering and costs. The PCM reconverts health to “Person-centred prevention” by promoting health education, prevention, early treatment of diseases, self-care, incentivizing individual resources, introducing and reinforcing protective factors, and buffering risk factors to improve individual resilience.
The PCM paradigm is defined as” The choice of the best possibilities for being the best human person,” which is also a political program.
In adolescence, a period of spiritual and psycho-biological formation, the PCM assumes fundamental importance throughout life because it builds an indelible trace for the future.
The Congress is held in three parts: the first is dedicated to the scientific bases of the Person-Centered Medicine interactionist and teleonomic paradigm, which will be followed by a panel dedicated to the paradigm change of Medicine. (in English) -November 13
Keynote speakers: Peter Sterling, the author of the Allostasis theory that revolutionized physiology and medical science, the fundament of the Person-Centered Medicine paradigm with other significant contributors to Medicine paradigm change .(November 13- h 15)
The second session is dedicated to adolescence. Speakers are contributors to the revolution of the paradigm of the adolescence theory. (November 13- 17,30-19,30)
The third session is dedicated to the Person-Centered Prevention paradigm, genetic and epigenetic damages induced by vaccines against SARS-COV 2, and early treatment of COVID-19.
( November 20 – h 15 in Italian-English)
Giuseppe R.Brera
Rector of the Ambrosiana University, Director of the Medical School of Milan, president of the World Health Committee and the Italian National Health Committee
Free access on zoom on registration
To give a contribution to the conference in panels (5-7′) send the enclosed abstract form to dr. Vito Galante within 7 November (1°-2° session, November 13 -3°session)

The conundrum of current anti-SARS-CoV-2 vaccines


The conundrum of current anti-SARS-CoV-2 vaccines

Maurizio Federico


The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has given rise to the urgent need for vaccines and therapeutic interventions to address the spread of the SARS-CoV-2 virus. SARS-CoV-2 vaccines in development, and those being distributed currently, have been designed to induce neutralizing antibodies using the spike protein of the virus as an immunogen. However, the immunological correlates of protection against the virus remain unknown. This raises questions about the efficacy of current vaccination strategies. In addition, safety profiles of several vaccines seem inadequate or have not yet been evaluated under controlled experimentation. Here, evidence from the literature regarding the efforts already made to identify the immunological correlates of protection against SARS-CoV-2 infection are summarized. Furthermore, key biological features of most of the advanced vaccines and considerations regarding their safety and expected efficacy are highlighted.

Full text